TEVA FY 2018 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$36B

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$18.9B-15.8% YoY

Gross Profit

$8.3B44.0% margin

Operating Income

-$1.6B-8.7% margin

Net Income

-$2.1B-11.4% margin

EPS (Diluted)

$-2.11

Cash Flow

Operating Cash Flow

$2.4B

Free Cash Flow

$1.8B

Stock-Based Comp.

$155M

Balance Sheet

Total Assets

$60.7B

Total Liabilities

$44.9B

Stockholders' Equity

$14.7B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18.9B	$22.4B	-15.8%
Gross Profit	$8.3B	$10.8B	-23.4%
Operating Income	-$1.6B	-$17.5B	+90.6%
Net Income	-$2.1B	-$16.3B	+86.8%